- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vital Chemtech Limited has announced a board meeting on May 30, 2025, approving its audited consolidated financial results for FY25.
1) **Revenue Performance:** Consolidated revenue rose sharply to ₹133.98 Cr, up 36% YoY from ₹98.27 Cr, supported by strong operational sales across the group.
2) **Profitability and EPS:** The company swung back to profit, reporting a net profit of ₹4.06 Cr versus a ₹1.30 Cr loss last year. Basic EPS stood at ₹1.69. Profit growth was driven by higher volumes and better cost control, lifting PBT to ₹6.21 Cr from last year’s loss before tax.
3) **Operational Costs:** Expenses increased to ₹129.77 Cr, mainly due to higher raw material consumption (₹107.39 Cr vs ₹74.44 Cr) and employee costs nearly doubling to ₹5.57 Cr. Depreciation rose to ₹4.97 Cr, reflecting new asset additions. Overall, cost increase aligned with revenue growth, indicating improved operational efficiency.
4) **Key Metrics:** Finance costs increased moderately to ₹2.17 Cr. Inventory and receivables grew with business expansion. EBITDA turned positive from losses last year.
5) **Balance Sheet / Cash Flow Health:** Long-term borrowings jumped to ₹40.31 Cr from ₹16.24 Cr, signaling debt-funded capex. Fixed assets nearly doubled to ₹83.55 Cr. Operating cash flow remained healthy at ₹6.16 Cr, despite heavy capex outflows of ₹45.78 Cr. Net working capital expanded due to higher inventories and receivables.
6) **Strategic Outlook:** The rise in fixed assets and borrowings points to capacity expansion or modernization plans, suggesting a growth focus. A new independent director with a finance background may strengthen governance.
**Final Takeaway:** Vital Chemtech is showing positive momentum with strong top-line growth and improved profitability after last year’s loss. Rising debt and capex reflect expansion ambitions but increase leverage risks. Retail investors should monitor debt management and execution of growth plans for sustained earnings improvement.